Stanford Medicine researchers are investigating new tactics to overcome cognitive loss, including that which occurs in Alzheimer's disease.
Four years after his death, possibly the greatest mystery famed neuroscientist Ben Barres ever sought to solve has become a bit less opaque.
This new issue of Stanford Medicine magazine explores scientific advances that are helping unlock the mysteries of the brain.
During cardiac surgery, patients’ blood levels of a substance highly predictive of Alzheimer’s disease jumped more than 5-fold.
The medical community has long seen the value of music in wellness, but our appreciation is growing because of its close link to mental and physical health.
Blood levels of a brain-derived substance in people in their 90s and 100s accurately predict how much longer they're going to live.
There's a lot we can do to improve brain health and counteract genetic factors for memory loss, Stanford neuroscientist Sharon Sha says in a podcast.
Stanford neurologist Sharon Sha explains that diet, exercise, cognitive activity and sleep can all boost your brain health.
A new study has identified T cells targeting the Epstein-Barr virus in autopsied Alzheimer's brains and in cerebrospinal fluid of Alzheimer's patients.
In this 1:2:1 podcast, host Paul Costello talks with Eugenia Zukerman, who is living with Alzheimer's disease and has a new book of poetry.
People with a mutation in an enzyme that breaks down alcohol may be at a higher risk for developing Alzheimer's disease, new research suggests.
This In the Spotlight Q&A features Garam Kim, a former professional violinist pursuing a PhD in neurosciences at Stanford.
Brain cells called microglia keep brains young by eliminating accumulations of protein debris. But their garbage-colllection ability fades with age.
Scientists studying cell death are working to understand how the body protects itself from disease and use that information to form better treatments.
Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.
With half of all cases of Alzheimer's disease and related dementias going undiagnosed, researchers develop app to help in early screening
